|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:FAM83A-LYN (FusionGDB2 ID:29215) |
Fusion Gene Summary for FAM83A-LYN |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: FAM83A-LYN | Fusion gene ID: 29215 | Hgene | Tgene | Gene symbol | FAM83A | LYN | Gene ID | 84985 | 4067 |
| Gene name | family with sequence similarity 83 member A | LYN proto-oncogene, Src family tyrosine kinase | |
| Synonyms | BJ-TSA-9 | JTK8|p53Lyn|p56Lyn | |
| Cytomap | 8q24.13 | 8q12.1 | |
| Type of gene | protein-coding | protein-coding | |
| Description | protein FAM83Atumor antigen BJ-TSA-9tumor-specific gene expressed in prostate protein | tyrosine-protein kinase Lynlck/Yes-related novel protein tyrosine kinasev-yes-1 Yamaguchi sarcoma viral related oncogene homolog | |
| Modification date | 20200313 | 20200327 | |
| UniProtAcc | Q86UY5 | P0DP58 | |
| Ensembl transtripts involved in fusion gene | ENST00000276699, ENST00000318462, ENST00000518448, ENST00000522648, ENST00000536633, ENST00000546351, ENST00000523819, | ENST00000420292, ENST00000519728, ENST00000520220, | |
| Fusion gene scores | * DoF score | 4 X 3 X 3=36 | 13 X 14 X 7=1274 |
| # samples | 4 | 15 | |
| ** MAII score | log2(4/36*10)=0.15200309344505 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(15/1274*10)=-3.08633087176042 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: FAM83A [Title/Abstract] AND LYN [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | FAM83A(124206388)-LYN(56910905), # samples:2 | ||
| Anticipated loss of major functional domain due to fusion event. | FAM83A-LYN seems lost the major protein functional domain in Tgene partner, which is a essential gene due to the frame-shifted ORF. FAM83A-LYN seems lost the major protein functional domain in Tgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. FAM83A-LYN seems lost the major protein functional domain in Tgene partner, which is a kinase due to the frame-shifted ORF. | ||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | FAM83A | GO:0007173 | epidermal growth factor receptor signaling pathway | 22886303 |
| Tgene | LYN | GO:0006468 | protein phosphorylation | 11517336 |
| Tgene | LYN | GO:0006974 | cellular response to DNA damage stimulus | 10891478|11517336 |
| Tgene | LYN | GO:0018108 | peptidyl-tyrosine phosphorylation | 7682714|11782428 |
| Tgene | LYN | GO:0046777 | protein autophosphorylation | 7682714 |
| Tgene | LYN | GO:0051272 | positive regulation of cellular component movement | 16467205 |
| Tgene | LYN | GO:0070304 | positive regulation of stress-activated protein kinase signaling cascade | 10891478 |
| Fusion gene breakpoints across FAM83A (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene breakpoints across LYN (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | LUAD | TCGA-78-7147-01A | FAM83A | chr8 | 124206388 | + | LYN | chr8 | 56910905 | + |
Top |
Fusion Gene ORF analysis for FAM83A-LYN |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 5CDS-3UTR | ENST00000276699 | ENST00000420292 | FAM83A | chr8 | 124206388 | + | LYN | chr8 | 56910905 | + |
| 5CDS-3UTR | ENST00000318462 | ENST00000420292 | FAM83A | chr8 | 124206388 | + | LYN | chr8 | 56910905 | + |
| 5CDS-3UTR | ENST00000518448 | ENST00000420292 | FAM83A | chr8 | 124206388 | + | LYN | chr8 | 56910905 | + |
| 5CDS-3UTR | ENST00000522648 | ENST00000420292 | FAM83A | chr8 | 124206388 | + | LYN | chr8 | 56910905 | + |
| 5CDS-3UTR | ENST00000536633 | ENST00000420292 | FAM83A | chr8 | 124206388 | + | LYN | chr8 | 56910905 | + |
| 5CDS-3UTR | ENST00000546351 | ENST00000420292 | FAM83A | chr8 | 124206388 | + | LYN | chr8 | 56910905 | + |
| Frame-shift | ENST00000276699 | ENST00000519728 | FAM83A | chr8 | 124206388 | + | LYN | chr8 | 56910905 | + |
| Frame-shift | ENST00000276699 | ENST00000520220 | FAM83A | chr8 | 124206388 | + | LYN | chr8 | 56910905 | + |
| Frame-shift | ENST00000318462 | ENST00000519728 | FAM83A | chr8 | 124206388 | + | LYN | chr8 | 56910905 | + |
| Frame-shift | ENST00000318462 | ENST00000520220 | FAM83A | chr8 | 124206388 | + | LYN | chr8 | 56910905 | + |
| Frame-shift | ENST00000518448 | ENST00000519728 | FAM83A | chr8 | 124206388 | + | LYN | chr8 | 56910905 | + |
| Frame-shift | ENST00000518448 | ENST00000520220 | FAM83A | chr8 | 124206388 | + | LYN | chr8 | 56910905 | + |
| Frame-shift | ENST00000522648 | ENST00000519728 | FAM83A | chr8 | 124206388 | + | LYN | chr8 | 56910905 | + |
| Frame-shift | ENST00000522648 | ENST00000520220 | FAM83A | chr8 | 124206388 | + | LYN | chr8 | 56910905 | + |
| Frame-shift | ENST00000536633 | ENST00000519728 | FAM83A | chr8 | 124206388 | + | LYN | chr8 | 56910905 | + |
| Frame-shift | ENST00000536633 | ENST00000520220 | FAM83A | chr8 | 124206388 | + | LYN | chr8 | 56910905 | + |
| Frame-shift | ENST00000546351 | ENST00000519728 | FAM83A | chr8 | 124206388 | + | LYN | chr8 | 56910905 | + |
| Frame-shift | ENST00000546351 | ENST00000520220 | FAM83A | chr8 | 124206388 | + | LYN | chr8 | 56910905 | + |
| intron-3CDS | ENST00000523819 | ENST00000519728 | FAM83A | chr8 | 124206388 | + | LYN | chr8 | 56910905 | + |
| intron-3CDS | ENST00000523819 | ENST00000520220 | FAM83A | chr8 | 124206388 | + | LYN | chr8 | 56910905 | + |
| intron-3UTR | ENST00000523819 | ENST00000420292 | FAM83A | chr8 | 124206388 | + | LYN | chr8 | 56910905 | + |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
Top |
Fusion Genomic Features for FAM83A-LYN |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| FAM83A | chr8 | 124206388 | + | LYN | chr8 | 56910904 | + | 2.63E-05 | 0.9999738 |
| FAM83A | chr8 | 124206388 | + | LYN | chr8 | 56910904 | + | 2.63E-05 | 0.9999738 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
 |
Top |
Fusion Protein Features for FAM83A-LYN |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/:124206388/:56910905) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| FAM83A | LYN |
| FUNCTION: Probable proto-oncogene that functions in the epidermal growth factor receptor/EGFR signaling pathway. Activates both RAS/MAPK and PI3K/AKT/TOR signaling cascades downstream of EGFR. Required for the RAS/MAPK signaling cascade activation upon EGFR stimulation, it also activates both signaling cascades independently of EGFR activation. {ECO:0000269|PubMed:22886303}. | FUNCTION: Acts in different tissues through interaction to nicotinic acetylcholine receptors (nAChRs) (PubMed:21252236). The proposed role as modulator of nAChR activity seems to be dependent on the nAChR subtype and stoichiometry, and to involve an effect on nAChR trafficking and its cell surface expression, and on single channel properties of the nAChR inserted in the plasma membrane. Modulates functional properties of nicotinic acetylcholine receptors (nAChRs) to prevent excessive excitation, and hence neurodegeneration. Enhances desensitization by increasing both the rate and extent of desensitization of alpha-4:beta-2-containing nAChRs and slowing recovery from desensitization. Promotes large amplitude ACh-evoked currents through alpha-4:beta-2 nAChRs. Is involved in regulation of the nAChR pentameric assembly in the endoplasmic reticulum. Shifts stoichiometry from high sensitivity alpha-4(2):beta-2(3) to low sensitivity alpha-4(3):beta-2(2) nAChR (By similarity). In vitro modulates alpha-3:beta-4-containing nAChRs. Reduces cell surface expression of (alpha-3:beta-4)(2):beta-4 and (alpha-3:beta-4)(2):alpha-5 nAChRs suggesting an interaction with nAChR alpha-3(-):(+)beta-4 subunit interfaces and an allosteric mode. Corresponding single channel effects characterized by decreased unitary conductance, altered burst proportions and enhanced desensitization/inactivation seem to depend on nAChR alpha:alpha subunit interfaces and are greater in (alpha-3:beta-2)(2):alpha-3 when compared to (alpha-3:beta-2)(2):alpha-5 nAChRs (PubMed:28100642). Prevents plasticity in the primary visual cortex late in life (By similarity). {ECO:0000250|UniProtKB:P0DP60, ECO:0000269|PubMed:21252236, ECO:0000269|PubMed:28100642}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for FAM83A-LYN |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
Top |
Fusion Gene PPI Analysis for FAM83A-LYN |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for FAM83A-LYN |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for FAM83A-LYN |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies